AI Article Synopsis
- Pregabalin (PGB) is commonly used for treating conditions like neuropathic pain, anxiety, and epilepsy but its exact therapeutic mechanisms are not fully understood.
- PGB was found to decrease the excitability of dentate gyrus granule cells (DGGCs) and also sped up the maturation of new DGGCs in mice.
- These effects suggest that PGB may lower activity in the dentate gyrus and influence neural plasticity, which could explain its therapeutic benefits.
Article Abstract
Pregabalin (PGB) is extensively prescribed to treat neurological and neuropsychiatrical conditions such as neuropathic pain, anxiety disorders, and epilepsy. Although PGB is known to bind selectively to the α2δ subunit of voltage-gated calcium channels, there is little understanding about how it exerts its therapeutic effects. In this article, we analyzed the effects of an in vivo chronic treatment with PGB over the physiology of dentate gyrus granule cells (DGGCs) using ex vivo electrophysiological and morphological analysis in adult mice. We found that PGB decreases neuronal excitability of DGGCs. In addition, PGB accelerates maturation of adult-born DGGCs, an effect that would modify dentate gyrus plasticity. Together, these findings suggest that PGB reduces activity in the dentate gyrus and modulates overall network plasticity, which might contribute to its therapeutic effects. Cover Image for this issue: doi: 10.1111/jnc.13783.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jnc.13740 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!